No Photo Available

Last Update

2016-12-31T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Fred Eshelman?

Dr. Fred N. Eshelman

HQ Phone: (910) 558-6885

Email: f***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Eshelman Ventures LLC

319 N. 3Rd Street Suite 301

Wilmington, North Carolina 28401

United States

Company Description

Local firm working w/ private healthcare company investments including startups, private equity funds & more. See Investment Criteria and View Portfolio. ... more

Find other employees at this company (1)

Background Information

Employment History

Food and Drug Administration

Chancellor

University of California , San Diego

Chancellor

North Carolina State University

Chancellor

University Professor Of Chemistry

Affiliations

Board Member
Innocrin Pharmaceuticals Inc

Board Member
InvestCorrectly

Advisory Board Member
Auven Therapeutics

Board Member
G1 Therapeutics , Inc.

Board Member
The Medicines Company

Board Member
Valeant Pharmaceuticals International

Board Member
Neoantigenics Inc

Board Member
Medikidz Limited

Board Member
Cellective BioTherapy Inc

Board Member
AeroMD

Steering Committee Member
Debt

Board of Governors
UNC School of Pharmacy

Board Member
Eyenovia , Inc.

Board Member
Meryx , Inc.

Board Member
Dignify Therapeutic , Inc.

Business Advisory Board Member
Princeton BioPharma Capital Partners LLC

Advisory Board Member
Celtic Therapeutics

Advisory Board Member
Cellona Therapeutics

Board Member
Accelerator Corporation

Executive Committee
N.C. Medical Foundation

Board Member
Computer Solutions

Board Member
Aton Pharma , Inc.

Board Member
Spotlight Health Inc

Board Member
PRIMECYTE , Inc.

Board Member
PPGx

Member
Board of Visitors

Board of Trustees
Gov. Beverly Perdue

Board Member
Can.Board Listed/Public CompaniesThe Medicines Company

Chairman
Furiex Pharmaceuticals, Inc.

Chief Executive Officer
PPD Inc

Senior Vice President, Development and Member of the Board of Directors
GlaxoSmithKline plc

Executive Committee
The Medical Foundation of North Carolina Inc

Board of Trustees
University of North Carolina Wilmington

Board Member
Carolina Business Coalition

Board Member
Association of Clinical Research Organizations

Board Member
Wilmington Chamber of Commerce

Member of the Pharmacy School's Board
Visitors

Faculty Member
University of Cincinnati

Member
School of Ph..

Member, Board
Princeton Pharma Holdings LLC.

Board of Advisors Member
Catalytix Inc

Board Member
Oriel Therapeutics Inc.

Chair, Board of Directors
SARCO , Inc.

Founder
Pharm

Education

UNC

UNC School of Pharmacy

B.S.

Harvard Business School

B.S.

pharmacy

University of North Carolina at Chapel Hill. He

BSc

pharmacy

UNC-CH

BSc

pharmacy

University of North Carolina , Chapel Hill

Bachelor of Science

pharmacy

UNC-Chapel Hill

Graduate of the Owner/President Management program

Harvard Business School

Ph.D.

University of North Carolina-Chapel Hill

Pharm.D.

The School of Pharmacy at UNC Chapel Hill

bachelor's degree

High Point University

bachelor's degree

pharmacy

Carolina

bachelor's degree

pharmacy

University of North Carolina at Chapel Hill

doctorate

pharmacy

University of Cincinnati

undergraduate degree

University of North Carolina at Chapel Hill

Web References (182 Total References)


Board of Directors - G1 Therapeutics

www.g1therapeutics.com [cached]

Fred Eshelman, PharmD

Fred Eshelman is the founder and principle of Eshelman Ventures LLC, investing in a variety of companies, primarily health care. Prior to that, he was the founding chairman of Furiex Pharmaceuticals (FURX, NASDAQ); the company was sold to Forest Labs/Actavis in July, 2014.
Previously, he founded and served as CEO and Executive Chairman for Pharmaceutical Product Development, Inc. (PPDI, NASDAQ) until sale of the company to private equity interests (Carlyle, Hellman & Friedman). His career has also included positions as Senior Vice President, Development and board member at Glaxo Inc., as well as various management positions at Beecham Laboratories and Boehringer Mannheim Pharmaceuticals. He serves on a number of of industry boards. Eshelman has served on the executive committee of the Medical Foundation of North Carolina and the board of the NC Biotechnology Center.
He is active in higher education, serving on the Board of Governors for the UNC System (chaired Audit Committee) and as an adjunct professor at the UNC School of Pharmacy, where he chairs the Board of Visitors. One of the top pharmacy programs in the US, in May 2008 the school was named the Eshelman School of Pharmacy, in recognition of his many contributions to the school and profession.
He has received many awards, including the Davie and Outstanding Service awards from UNC-Chapel Hill and outstanding alumnus awards from UNC and University of Cincinnati schools of pharmacy. He has also received the Ernst & Young Entrepreneur of the Year and the NC Entrepreneur Hall of Fame Award.
Dr. Eshelman holds a BSc pharmacy from UNC-CH, a doctor of pharmacy from the University of Cincinnati and completed a hospital residency at Cincinnati General Hospital. He completed the Owner/President/Manager program at Harvard Business School.


Board of Directors | The Medicines Company

www.themedicinescompany.com [cached]

Fredric N. Eshelman, Pharm.D Non-Executive Chairman, Member of Audit Committee

Fredric N. Eshelman has been a director and chairman since August 2015. Dr. Eshelman has more than 35 years of strategic development, executive, operational and financial leadership experience in the pharmaceutical and healthcare industries. Dr. Eshelman was the founder of Pharmaceutical Product Development, Inc. (PPD) and founding chairman of Furiex Pharmaceuticals, Inc. In 2014, Dr. Eshelman founded Eshelman Ventures, LLC, an investment company focused on healthcare companies. From 2009 to 2014, Dr. Eshelman served as Chairman of the Board of Furiex. From 2009 to 2011, he served as Executive Chairman of PPD. He also served as Chief Executive Officer of PPD from 1990 to 2009 and as Vice Chairman of its Board of Directors from 1993 to 2009. Dr. Eshelman currently serves on the board of directors of AeroMD, Cellective Biotherapy, Inc., Dignify Therapeutic, Inc., Eyenovia, Inc., G1 Therapeutics, Inc., Innocrin Pharmaceuticals, Inc., Medikidz USA, Inc., Meryx, Inc. and Neoantigenics LLC and Valeant Pharmaceuticals International, Inc., and the advisory board of Auven Therapeutics.
Dr. Eshelman has served on the executive committee of the Medical Foundation of North Carolina, was on the Board of Trustees for UNC-W and in 2011 was appointed by the NC General Assembly to serve on the Board of Governors for the state's multi-campus university system as well as the NC Biotechnology Center. In addition, he chairs the board of visitors for the School of Pharmacy at UNC-CH. One of the top pharmacy programs in the United States, in May 2008 the school was named the UNC Eshelman School of Pharmacy in recognition of his many contributions to the school and the profession. Dr. Eshelman has received many awards including the Davie and Distinguished Service Awards from UNC and Outstanding Alumnus from both the UNC and University of Cincinnati schools of pharmacy, as well as the NC Entrepreneur Hall of Fame Award. He has received the doctor of pharmacy from the University of Cincinnati, completed a residency at Cincinnati General Hospital and a BS in pharmacy from UNC-CH. He is a graduate of the OPM program at Harvard Business School.


Board of Directors | Innocrin

innocrinpharma.com [cached]

Fred Eshelman, PharmD. Eshelman Ventures LLC

Fred Eshelman is the founder and principle of Eshelman Ventures LLC, investing in a variety of companies, primarily health care. Prior to that, he was the founding chairman of Furiex Pharmaceuticals (FURX, NASDAQ); the company was sold to Forest Labs/Actavis in July, 2014.
Previously, he found and served as CEO and Executive Chairman of Pharmaceutical Product Development, Inc. (PPDI, NASDAQ) until sale of the company to private equity interests (Carlyle, Hellman & Friedman). His career has also included positions as Senior Vice President, Development and board member of Glaxo Inc., as well as various management positions at Beecham Laboratories and Boehringer Mannheim Pharmaceuticals. He serves on a number of industry boards.
He is active in higher education, serving on the Board of Governors for the UNC System (chaired Audit Committee) and as an adjunct professor at the UNC School of Pharmacy, where he chairs the Board of Visitors. One of the top pharmacy programs in the US, in May 2008 the school was named the Eshelman School of Pharmacy, in recognition of his many contributions to the school and profession.
Dr. Eshelman holds a BSc pharmacy from UNC-CH, a doctor of pharmacy from the University of Cincinnati and completed a hospital residency at Cincinnati General Hospital. He completed the Owner/President/Manager program at Harvard Business School.


Investors | Innocrin

www.innocrinpharma.com [cached]

Fred Eshelman is a founder of Eshelman Ventures LLC, an investment company primarily interested in private healthcare companies. Dr. Eshelman typically serves on the board of portfolio companies. Previously he founded and served as CEO and Executive Chairman of Pharmaceutical Product Development (PPDI, NASDAQ) prior to the sale of the company to private equity interests.

After PPD he served as Founding Chairman and largest shareholder of Furiex Pharmaceuticals (FURX, NASDAQ), a company which licensed and rapidly developed new medicines. Furiex was sold to Forest Labs/Actavis in July, 2014.


Dignify Therapeutics Completes Preferred Equity Financing | First Flight Venture Center

ffvcnc.org [cached]

Founded by Fred Eshelman, Eshelman Ventures is an investment company primarily interested in private healthcare companies.

Similar Profiles

Other People with this Name

Other people with the name Eshelman

Peter Eshelman
Petroleum Traders Corporation

Michael Eshelman
Membership Marketing Support Services

Linda Eshelman
McNees Wallace & Nurick LLC

Henry Eshelman
PM Realty Group Ltd

Ryan Eshelman
Tidewater Glazing Inc

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory